Overview
Title: Addressing Safety Testing of Drug Metabolites (MIST) in Drug Development
Summary
Our latest webinar discusses the importance of MIST, taking you through a case study and covering the following topics:
• Regulatory Guidance
• Why to Conduct MIST in Drug Development
• When to Conduct MIST in Drug Development
• When and How to Conduct Met ID to Address MIST
Speaker
Dr. Peter Wang is the Senior Director of Drug Metabolism and Biotransformation at WuXi AppTec, Lab Testing Division. In his current role, he directs operations of the Drug Metabolism department, providing operational, client, and project management support. Dr. Wang has extensive experience in metabolite identification, having worked in in vitro and in vivo DMPK-related fields for more than 15 years. Prior to joining WuXi AppTec in 2008, Peter was a senior scientist at FMC Cooperation, where he served as Study Director for agrochemical metabolism studies in plants and animals.